Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PRNP | P04156 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21395484 | 0.75 | LMNA (0.61) | GAALMNAMAPTMEN1KMT2A | |
| SCHEMBL2750042 | 0.68 | F2RL3 (0.46) | GAALMNAMAPTMEN1KMT2A | |
| SCHEMBL3908559 | 0.67 | ALDH1A1 (0.54) | GAALMNAMAPTMEN1KMT2A | |
| SCHEMBL6118333 | 0.67 | SMN1; SMN2 (0.59) | GAALMNAMAPTMEN1KMT2A | |
| SCHEMBL21412413 | 0.66 | CA2 (0.53) | GAALMNAMAPTMEN1KMT2A | |
| SCHEMBL18863820 | 0.64 | HSD17B10 (0.41) | GAAALDH1A1 | |
| SCHEMBL17281505 | 0.63 | NPC1 (0.44) | GAALMNAMAPTMEN1KMT2A | |
| SCHEMBL19001500 | 0.62 | HRH3 (0.40) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1770192 | 0.61 | NPC1 (0.46) | GAALMNAMAPTMEN1KMT2A | |
| SCHEMBL20710919 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-20210384434-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | CLAP CO., LTD. (KR) | 2021-12-09 | — | — | US | disclosed |
| US-10388881-B2 | Sorting of carbon nanotubes | BASF SE (DE) | 2019-08-20 | — | — | US | disclosed |
| US-10020456-B2 | Ether-based polymers as photo-crosslinkable dielectrics | BASF SE (DE) | 2018-07-10 | — | — | US | disclosed |
| US-20170250358-A1 | ETHER-BASED POLYMERS AS PHOTO-CROSSLINKABLE DIELECTRICS | BASF SE (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20170229657-A1 | SORTING OF CARBON NANOTUBES | CLAP CO., LTD. (KR) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210384434-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | IPO11, CYP1B1, IDO1 | GAA 3672/4885LMNA 2683/4885MAPT 2054/4885 |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | IPO11, CYP1B1, IDO1 | GAA 3672/4885LMNA 2683/4885MAPT 2054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.